Position in ALKS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,881,725
+$936,925 QoQ
Shares Held
55,000
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 27 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $87,470,140 across 16 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
205,871 | $34,697,498 | |
| 2 | ZTS |
Zoetis Inc.
|
228,467 | $16,417,638 | |
| 3 | VTRS |
Viatris Inc
|
522,705 | $8,300,555 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
13,120 | $7,108,809 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
165,300 | $4,068,033 | |
| 6 | ALKS |
Alkermes plc.
This page
|
55,000 | $2,881,725 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
23,600 | $2,618,184 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
60,000 | $2,080,200 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,881,725 | 55,000 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,944,800 | 55,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,538,900 | 55,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,963,000 | 332,100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,109,424 | 318,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,165,340 | 217,000 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $6,240,920 | 217,000 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $6,174,594 | 220,600 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $5,299,590 | 219,900 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,742,664 | 175,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,860,048 | 175,200 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $789,882 | 28,200 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $741,810 | 23,700 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $569,438 | 20,200 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $527,826 | 20,200 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $451,066 | 20,200 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $601,758 | 20,200 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $541,986 | 20,600 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $746,646 | 32,100 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,125,660 | 36,500 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $894,980 | 36,500 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $567,872 | 30,400 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $606,480 | 30,400 | Shares | Sole | 2021-02-11 | |
| 2020-06-30 | $467,781 | 24,100 | Shares | Sole | 2020-08-26 | |
| No filing history on record for this holder in this stock. | ||||||